Key facts
- This page summarizes Alison Bauerlein's Form 4 filing for Inogen Inc (INGN).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Dec 2021, 17:15.
Alison Bauerlein - 01 Dec 2021 Form 4 Insider Report for Inogen Inc (INGN)
- Reporting relationship
- EVP, Finance, & CFO
- Issuer ticker
- INGN
- Reported as of
- 01 Dec 2021
- Net transaction value
- -$14,533
- SEC form
- 4
- Accepted by SEC
- 03 Dec 2021, 17:15:48 UTC
- Prior SEC filing
- 03 Sep 2021
- Next SEC filing
- 07 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alison Bauerlein
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Alison Bauerlein filed Form 4 for Inogen Inc (INGN) on 03 Dec 2021.
Change
- Previous filing in this sequence was filed on 03 Sep 2021.
- Current net transaction value: -$14,533.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INGN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +546
- Change %
- +1.6%
- Price
- $0.000000
- Shares after
- 34,392
- Date
- 01 Dec 2021
- Ownership
- Direct
- Footnotes
- F1
INGN
transaction
Common Stock
Tax liability
- Transaction value
- $14,533
- Shares
- -490
- Change %
- -1.4%
- Price
- $29.66
- Shares after
- 33,902
- Date
- 01 Dec 2021
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INGN
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -546
- Change %
- -10%
- Price
- $0.000000
- Shares after
- 4,915
- Date
- 01 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 546
- Exercise price
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Shares beneficially owned are 30,155 shares more than the previously filed Form 4s due to an error reporting the shares owned on December 15, 2020. An amendment to the original Form 4 has been filed to correct the error.
Footnote F2
The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2021.
Footnote F3
Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
Footnote F4
Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month, subject to the reporting person continuing to be a service provider through each such vesting date.